SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 472 filers reported holding SEAGEN INC in Q3 2021. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $3,190,602 | +1137.9% | 16,578 | +1202.3% | 0.29% | +932.1% |
Q1 2023 | $257,744 | -96.7% | 1,273 | -97.8% | 0.03% | -95.4% |
Q3 2022 | $7,807,000 | -3.5% | 57,053 | +24.8% | 0.60% | -5.3% |
Q2 2022 | $8,089,000 | +31.9% | 45,715 | +7.4% | 0.64% | +30.7% |
Q1 2022 | $6,134,000 | -23.4% | 42,580 | -17.8% | 0.49% | -2.2% |
Q4 2021 | $8,013,000 | +134.2% | 51,829 | +157.3% | 0.50% | +136.5% |
Q3 2021 | $3,421,000 | +9.8% | 20,146 | +2.1% | 0.21% | +14.7% |
Q2 2021 | $3,116,000 | – | 19,739 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 47,288,259 | $7,465,870,000 | 32.79% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 145,000 | $22,868,000 | 6.04% |
Lagoda Investment Management, L.P. | 59,780 | $9,438,000 | 4.40% |
Avidity Partners Management LP | 640,000 | $101,043,000 | 2.73% |
PFM Health Sciences, LP | 482,985 | $76,254,000 | 2.39% |
Boxer Capital, LLC | 400,000 | $63,152,000 | 2.23% |
Redmile Group, LLC | 771,385 | $121,786,000 | 1.80% |
Woodline Partners LP | 577,655 | $91,200,000 | 1.70% |
Rhenman & Partners Asset Management AB | 157,925 | $24,933,000 | 1.69% |
Parkman Healthcare Partners LLC | 45,176 | $7,132,000 | 1.56% |